{
  "id": 13992594,
  "title": "Bristol Myers dips on ‘confounding’ lung drug results",
  "url": "https://urgent.news/2026/10/12/bristol-myers-dips-on-confounding-lung-drug-results",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-12T15:35:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/bristol-myers-admilparant-lpa1-ipf-aloft-results-contineum/832715/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}